The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Terminal sugars of Fc glycans influence antibody effector functions of IgGs
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fcγ receptors as regulators of immune responses
Nimmerjahn, F., & Ravetch, J. V. (2008) · Nature Reviews Immunology · doi:10.1038/nri2206 · Cited by 2,947
Shields, R. L., Lai, J., Keck, R., O'Connell, L. Y., Hong, K., Meng, Y. G., Weikert, S. H. A., & Presta, L. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202069200 · Cited by 1,835
Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation
Kaneko, Y., Nimmerjahn, F., & Ravetch, J. V. (2006) · Science · doi:10.1126/science.1129594 · Cited by 1,754
Deisenhofer, J. (1981) · PubMed · Cited by 1,422
Deisenhofer, J. (1981) · Biochemistry · doi:10.1021/bi00512a001 · Cited by 1,333
The Impact of Glycosylation on the Biological Function and Structure of Human Immunoglobulins
Arnold, J. N., Wormald, M. R., Sim, R. B., Rudd, P. M., & Dwek, R. A. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141702 · Cited by 1,307
Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc
Anthony, R. M., Nimmerjahn, F., Ashline, D. J., Reinhold, V. N., Paulson, J. C., & Ravetch, J. V. (2008) · Science · doi:10.1126/science.1154315 · Cited by 849
Malhotra, R., Wormald, M. R., Rudd, P. M., Fischer, P. B., Dwek, R. A., & Sim, R. B. (1995) · Nature Medicine · doi:10.1038/nm0395-237 · Cited by 786
Umaña, P., Jean–Mairet, J., Moudry, R., Amstutz, H., & Bailey, J. E. (1999) · Nature Biotechnology · doi:10.1038/6179 · Cited by 764
Krapp, S., Mimura, Y., Jefferis, R., Huber, R., & Sondermann, P. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)01250-0 · Cited by 674
Tao, M. H., & Morrison, S. L. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.8.2595 · Cited by 530
Diversity in cell surface sialic acid presentations: implications for biology and disease
Varki, N. M., & Varki, A. (2007) · Laboratory Investigation · doi:10.1038/labinvest.3700656 · Cited by 515
Glycoengineering: The effect of glycosylation on the properties of therapeutic proteins
Sinclair, A. M., & Elliott, S. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20319 · Cited by 461
Raju, T. S., Briggs, J. B., Borge, S. M., & Jones, A. J. S. (2000) · Glycobiology · doi:10.1093/glycob/10.5.477 · Cited by 452
Self-citationScallon, B. J., Tam, S. H., McCarthy, S. G., Cai, A. N., & Raju, T. S. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2006.09.005 · Cited by 396
Self-citationControl of Recombinant Monoclonal Antibody Effector Functions by Fc N‐Glycan Remodeling in Vitro
Hodoniczky, J., Zheng, Y. Z., & James, D. C. (2005) · Biotechnology Progress · doi:10.1021/bp050228w · Cited by 393
Sauer-Eriksson, A. E., Kleywegt, G. J., Uhlén, M., & Jones, T. A. (1995) · Structure · doi:10.1016/s0969-2126(01)00157-5 · Cited by 372
The Carbohydrate at FcγRIIIa Asn-162
Ferrara, C., Stuart, F., Sondermann, P., Brünker, P., & Umaña, P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510171200 · Cited by 354
Davies, J., Jiang, L., Pan, L., LaBarre, M. J., Anderson, D., & Reff, M. (2001) · Biotechnology and Bioengineering · doi:10.1002/bit.1119 · Cited by 327
Effect of glycosylation on antibody function: implications for genetic engineering
Wright, A., & Morrison, S. L. (1997) · Trends in Biotechnology · doi:10.1016/s0167-7799(96)10062-7 · Cited by 312
Ferrara, C., Brünker, P., Suter, T., Moser, S., Püntener, U., & Umaña, P. (2006) · Biotechnology and Bioengineering · doi:10.1002/bit.20777 · Cited by 305
Antibody therapeutics: isotype and glycoform selection
Jefferis, R. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.9.1401 · Cited by 294
Structural Comparison of Fucosylated and Nonfucosylated Fc Fragments of Human Immunoglobulin G1
Matsumiya, S., Yamaguchi, Y., Saito, J.-I., Nagano, M., Sasakawa, H., Otaki, S., Satoh, M., Shitara, K., & Kato, K. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.02.034 · Cited by 278
Structural and numerical variations of the carbohydrate moiety of immunoglobulin G.
Mizuochi, T., Taniguchi, T., Shimizu, A., & Kobata, A. (1982) · The Journal of Immunology · doi:10.4049/jimmunol.129.5.2016 · Cited by 244
Niwa, R., Natsume, A., Uehara, A., Wakitani, M., Iida, S., Uchida, K., Satoh, M., & Shitara, K. (2005) · Journal of Immunological Methods · doi:10.1016/j.jim.2005.08.009 · Cited by 244
The α1-6-fucosyltransferase gene and its biological significance
Miyoshi, E. (1999) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(99)00166-x · Cited by 221
Lectin-resistant CHO glycosylation mutants
Patnaik, S. K., & Stanley, P. (2006) · Methods in Enzymology · doi:10.1016/s0076-6879(06)16011-5 · Cited by 218
Structure and function of the constant regions of immunoglobulins
Beale, D., & Feinstein, A. (1976) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583500002390 · Cited by 206
Zhou, Q., Shankara, S., Roy, A., Qiu, H., Estes, S., McVie‐Wylie, A., Culm‐Merdek, K., Park, A., Pan, C., & Edmunds, T. (2008) · Biotechnology and Bioengineering · doi:10.1002/bit.21598 · Cited by 184
Non-fucosylated therapeutic antibodies as next-generation therapeutic antibodies
Satoh, M., Iida, S., & Shitara, K. (2006) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.6.11.1161 · Cited by 175
Imai-Nishiya (2007) · doi:10.1186/1472-6750-7-84 · Cited by 157
Structural mimicry of a native protein by a minimized binding domain
Starovasnik, M. A., Braisted, A. C., & Wells, J. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10080 · Cited by 155
Structural changes of immunoglobulin G oligosaccharides with age in healthy human serum
Yamada, E., Tsukamoto, Y., Sasaki, R., Yagyu, K., & Takahashi, N. (1997) · Glycoconjugate Journal · doi:10.1023/a:1018582930906 · Cited by 151
Jones, A. J. S., Papac, D. I., Chin, E. H., Keck, R. G., Baughman, S. A., Lin, Y. S., Kneer, J., & Battersby, J. E. (2007) · Glycobiology · doi:10.1093/glycob/cwm017 · Cited by 137
Raju, T. S., Briggs, J. B., Chamow, S. M., Winkler, M. E., & Jones, A. J. S. (2001) · Biochemistry · doi:10.1021/bi010475i · Cited by 122
Self-citationRyan, M. H., Petrone, D., Nemeth, J. F., Barnathan, E., Björck, L., & Jordan, R. E. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.10.043 · Cited by 122
Mimura, Y., Lund, J., Church, S., Dong, S., Li, J., Goodall, M. D., & Jefferis, R. (2001) · Journal of Immunological Methods · doi:10.1016/s0022-1759(00)00308-2 · Cited by 121
Wright, A. M., Sato, Y., Okada, T., Chang, K. H., Endo, T., & Morrison, S. L. (2000) · Glycobiology · doi:10.1093/glycob/10.12.1347 · Cited by 119
Ghirlando, R., Lund, J., Goodall, M. D., & Jefferis, R. (1999) · Immunology Letters · doi:10.1016/s0165-2478(99)00029-2 · Cited by 115
Glycosylation in the Fc domain of IgG increases resistance to proteolytic cleavage by papain
Raju, T. S., & Scallon, B. J. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.01.030 · Cited by 112
Self-citationMillward, T. A., Heitzmann, M., Bill, K., Längle, U., Schumacher, P., & Forrer, K. (2007) · Biologicals · doi:10.1016/j.biologicals.2007.05.003 · Cited by 91
Schuster, M., Umaña, P., Ferrara, C., Brünker, P., Gerdes, C. A., Waxenecker, G., Wiederkum, S., Schwager, C., Loibner, H., Himmler, G., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4212 · Cited by 91
A journey to the world of glycobiology
Kobata, A. (2000) · Glycoconjugate Journal · doi:10.1023/a:1011006122704 · Cited by 86
Yamaguchi, Y., Kato, K., Shindo, M., Aoki, S., Furusho, K., Koga, K., Takahashi, N., Arata, Y., & Shimada, I. (1998) · Journal of Biomolecular NMR · doi:10.1023/a:1008392229694 · Cited by 76
Fc Glycans Terminated with N-Acetylglucosamine Residues Increase Antibody Resistance to Papain
Raju, T. S., & Scallon, B. J. (2007) · Biotechnology Progress · doi:10.1021/bp070118k · Cited by 76
Self-citationRaju, T. S. (2003) · Cited by 59
Self-citationScallon, B. J., McCarthy, S. G., Radewonuk, J., Cai, A., Naso, M. F., Raju, T. S., & Capocasale, R. J. (2007) · International Immunopharmacology · doi:10.1016/j.intimp.2007.01.014 · Cited by 35
Self-citationHamako, J., Matsui, T., Ozeki, Y., Mizuochi, T., & Titani, K. (1993) · Comparative Biochemistry and Physiology Part B Comparative Biochemistry · doi:10.1016/0305-0491(93)90056-b · Cited by 31
Varki, A. P. (1996) · Glycobiology · doi:10.1093/glycob/6.7.707 · Cited by 27
Cited by
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
“cellular cytotoxicity (ADCC) (667–670) (671) that are relevant to biotechnology (672, 673).”
BackgroundThe etiology of rheumatoid arthritis
Scherer, H. U., Häupl, T., & Burmester, G. R. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102400 · Cited by 881
A systematic approach to protein glycosylation analysis: a path through the maze
Mariño, K., Bones, J., Kattla, J. J., & Rudd, P. M. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.437 · Cited by 628
A Functional Role for Antibodies in Tuberculosis
Lu, L. L., Chung, A. W., Rosebrock, T. R., Ghebremichael, M., Yu, W. H., Grace, P. S., Schoen, M. K., Tafesse, F., Martin, C., Leung, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.08.072 · Cited by 571
Antibody Therapeutics in Cancer
Sliwkowski, M. X., & Mellman, I. (2013) · Science · doi:10.1126/science.1241145 · Cited by 543
Metadata
- Authors
- Raju, T. S.
- Venue
- Current Opinion in Immunology
- Publisher
- Elsevier BV
- Published
- 2008-08
- Volume
- 20
- Issue
- 4
- Pages
- 471-478
- ISSN
- 0952-7915 (ISSN-L)
- OpenAlex
- W2136007354
- Cited by
- 521
- References
- 49
- FWCI
- 1.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.